WhaleCreep
HomeFunds › Carlyle Group Inc.

Carlyle Group Inc.: 13F holdings, Q2 2026

Hedge fund · SEC EDGAR filings (CIK 1527166) · Explore on the interactive board

Carlyle Group Inc. disclosed 19 US equity positions worth $10.0bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 7, 2026). Its largest position is MDLN at 73.8% of the reported book, followed by SARO, PHAT. The top ten holdings are 99.9% of the book, and the portfolio behaves like about 2 equal-weight positions. Versus the prior filing it opened 3 new positions, added to 2, reduced 1 and exited 4. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.

This manager's most recent filing is 3934 quarter(s) behind the newest quarter on file. Treat these figures as history, not current positioning.
$10.0bnreported US equity book
19positions
73.8%largest position
99.9%top 10 weight
1.64effective positions (1/HHI)
2quarters on file since Q1 2026

What does Carlyle Group Inc. own? Top holdings as of June 30, 2026

Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 3 new, 2 added, 1 reduced, 4 exited.

#StockSectorWeightValueSharesΔ sharesAction
1 MDLN Medline Inc Healthcare 73.8%$7.4bn187,083,713 0% held
2 SARO Standardaero Inc Industrials 25.3%$2.5bn84,587,035 0% held
3 PHAT Phathom Pharmaceuticals Inc Healthcare 0.4%$37.9m3,496,808 0% held
4 INVH Invitation Homes Inc Real Estate 0.2%$20.0m662,900 -0% held
5 PONY Pony Ai Inc Technology 0.2%$16.4m2,362,447 0% held
6 GETY Getty Images Holdings Inc 0.1%$5.4m6,234,252 0% held
7 SPRB Spruce Biosciences Inc 0.0%$2.1m38,620 0% held
8 SPWR SunPower Inc 0.0%$1.6m2,343,750 441% added
9 ACET Adicet Bio Inc 0.0%$1.6m184,295 0% held
10 FWRD Forward Air Corp 0.0%$1.4m107,214 0% held
11 OKUR Onkure Therapeutics Inc 0.0%$1.2m269,895 0% held
12 DNUT Krispy Kreme Inc Consumer Defensive 0.0%$1.2m340,748 0% held
13 QTTB Q32 Bio Inc 0.0%$769.0k60,363 -95% reduced
14 REPX Riley Exploration Permian In 0.0%$530.4k16,092 new
15 NBIS Nebius Group N.V. Communication Services 0.0%$509.8k1,846 new
16 HOOD Robinhood Mkts Inc Financial Services 0.0%$474.6k4,733 40% added
17 JSPR Jasper Therapeutics Inc 0.0%$448.9k1,066,189 0% held
18 NABL N-able Inc Technology 0.0%$344.0k93,732 0% held
19 METC Ramaco Res Inc Basic Materials 0.0%$287.7k21,743 new

What did Carlyle Group Inc. sell? Positions exited since the previous filing

StockPrior weightPrior value
CUBE CubeSmart86.9%$8.1m
HTFL Heartflow Inc5.3%$497.3k
SYRE Spyre Therapeutics Inc5.2%$485.2k
Exicure Inc2.6%$239.6k

Sector mix

SectorWeight
Healthcare74.2%
Industrials25.3%
Real Estate0.2%
Technology0.2%
Consumer Defensive0.0%
Communication Services0.0%

Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.

Filing history

QuarterPositionsEquity value
Q2 202619$10.0bn
Q1 202620$10.6bn

How concentrated is Carlyle Group Inc.'s portfolio?

Across every quarter Carlyle Group Inc. has filed, its median largest position is 76.1% of the book and its median top-ten weight is 99.9%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 4.0 completed holding spells, the median lasted 1.0 quarters; 19.0 positions are still open and their final length is unknown.